Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment
Clinical trial NCT06830694 · RECRUITING
Trial details
- NCT number
- NCT06830694
- Sponsor
- Se-Hoon Lee
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-13
- Primary completion
- 2027-03-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.